A detailed history of E. Ohman J:Or Asset Management Ab transactions in Incyte Corp stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 3,500 shares of INCY stock, worth $251,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,500
Previous 3,500 -0.0%
Holding current value
$251,020
Previous $212 Million 9.04%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $197,925 - $233,065
3,500 New
3,500 $199 Million
Q3 2023

Feb 06, 2024

BUY
$57.77 - $65.93 $508,376 - $580,184
8,800 New
8,800 $508 Million
Q3 2022

Apr 05, 2024

SELL
$66.18 - $82.86 $589,002 - $737,454
-8,900 Closed
0 $0
Q1 2022

Apr 05, 2024

BUY
$66.02 - $79.71 $587,578 - $709,419
8,900 New
8,900 $707 Million
Q4 2021

Apr 05, 2024

SELL
$63.34 - $74.11 $506,720 - $592,880
-8,000 Closed
0 $0
Q3 2021

Apr 05, 2024

SELL
$68.67 - $84.02 $103,005 - $126,030
-1,500 Reduced 15.79%
8,000 $550 Million
Q4 2020

Apr 05, 2024

BUY
$80.74 - $97.7 $427,922 - $517,810
5,300 Added 126.19%
9,500 $826 Million
Q4 2019

Apr 05, 2024

SELL
$73.04 - $95.72 $299,464 - $392,452
-4,100 Reduced 49.4%
4,200 $367 Million
Q3 2019

Apr 05, 2024

BUY
$72.82 - $86.52 $87,383 - $103,824
1,200 Added 16.9%
8,300 $616 Million
Q2 2019

Apr 05, 2024

BUY
$73.52 - $88.7 $110,280 - $133,050
1,500 Added 26.79%
7,100 $603 Million
Q2 2018

Apr 05, 2024

BUY
$60.85 - $83.98 $127,785 - $176,358
2,100 Added 60.0%
5,600 $375 Million
Q1 2018

Apr 05, 2024

SELL
$83.06 - $100.98 $124,590 - $151,470
-1,500 Reduced 30.0%
3,500 $292 Million
Q3 2017

Apr 05, 2024

BUY
$109.15 - $138.27 $10,915 - $13,827
100 Added 2.04%
5,000 $584 Million
Q2 2017

Apr 05, 2024

BUY
N/A
1,000 Added 25.64%
4,900 $617 Million
Q4 2016

Apr 05, 2024

BUY
N/A
700 Added 21.88%
3,900 $391 Million
Q4 2014

Apr 05, 2024

BUY
N/A
3,200
3,200 $234 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.